Illinois Medical Practice Act advertising rules — a marketing guide for physicians and practices
A practical field guide for marketing leads and practice operators serving Illinois-licensed physicians. Written against the Illinois Medical Practice Act of 1987 (225 ILCS 60), the Illinois Department of Financial and Professional Regulation (IDFPR) professional-conduct rules at 68 Ill. Admin. Code 1285, and the Illinois Consumer Fraud and Deceptive Business Practices Act as it applies to healthcare advertising.
- The Illinois Medical Practice Act at 225 ILCS 60/22(A)(3) makes false, deceptive or misleading advertising a ground for discipline — up to and including licence revocation, and it applies to every physician who holds an Illinois licence, wherever the advertising is placed.
- The Illinois Medical Disciplinary Board, seated within IDFPR, enforces the Act. It does not preapprove advertising. Every campaign is reviewable after the fact against 68 Ill. Admin. Code 1285 and against the general standard of the Act itself.
- Testimonials, before-and-after imagery, and outcome claims are the three highest-risk surfaces in Illinois. Each requires clear identification, disclosure of any consideration given, and a "results not typical" line where the outcome is not the typical clinical result.
- Illinois advertising rules layer on top of federal HIPAA, the FTC Act, TCPA, CAN-SPAM and ADA. Nothing about Illinois-specific rules relaxes any federal requirement — everything is additive.
- The safe operating stance is: verifiable claims, disclosed consideration, current information, identifiable licensee, and no superlatives without substantiation. Everything else invites an IDFPR inquiry.
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
On this page
- Who enforces physician advertising in Illinois
- What Illinois calls "advertising" — and the deceptive-practice standard
- Testimonials, before-and-after, and outcome claims
- Credentials, specialties and titles
- Discounts, comparative claims and superlatives
- Digital advertising — SEO, ads, social, review platforms
- Enforcement patterns and disciplinary risk
- Federal overlay — HIPAA, FTC, TCPA, ADA
- FAQ
Who enforces physician advertising in Illinois
Two Illinois bodies matter for a physician marketing programme. The Illinois Medical Disciplinary Board is the professional-review body under 225 ILCS 60/7. IDFPR — the Illinois Department of Financial and Professional Regulation — is the licensing and enforcement agency that acts on the Board's recommendations under 225 ILCS 60/5 and 60/22. The Illinois Attorney General enforces the Consumer Fraud and Deceptive Business Practices Act, 815 ILCS 505, which reaches healthcare advertising when the conduct is deceptive under a consumer-protection lens rather than a professional one.
Illinois-licensed physicians are subject to the Act regardless of where the advertising is placed. A physician who lives in Illinois and runs an ad campaign targeting Iowa patients through Illinois-facing digital properties is still an Illinois licensee for enforcement purposes. Multi-state groups therefore end up under the strictest of the states they touch, and Illinois is one of the strict ones for testimonial and outcome-claim scrutiny.
Who is covered
The Act covers every person licensed under 225 ILCS 60 — MDs and DOs — and reaches to their employees, contractors and agents to the extent those parties are acting on the licensee's behalf. A marketing agency that publishes an ad in a physician's name is not itself an IDFPR licensee, but the physician remains responsible for the content under 225 ILCS 60/22 and cannot outsource that responsibility by contract. That is why every US healthcare engagement at Ichelon Consulting US runs advertising through a named-licensee sign-off step before publication.
Board-approved framing is unavailable
Neither the Board nor IDFPR issues advertising approvals. Any campaign or agency that claims to be "Illinois board-approved" or "IDFPR-endorsed" is itself running afoul of the deceptive-practice standard. The correct phrasing on any pitch, decking, or website is that a campaign has been "reviewed against Illinois medical-board advertising rules" — that phrasing is truthful, non-implicative, and defensible.
What Illinois calls "advertising" — and the deceptive-practice standard
Illinois takes an expansive view of what constitutes advertising for medical-board purposes. It includes paid media in any channel — print, broadcast, out-of-home, digital display, paid search, paid social, sponsored content — and also unpaid content published by or on behalf of the licensee: a practice website, a Google Business Profile, a physician's professional social-media account, review-platform responses, patient-education videos, downloadable guides, webinars, and podcast appearances in a promotional context.
The deceptive-practice standard at 225 ILCS 60/22(A)(3) covers three related failure modes. First, a material misrepresentation: an affirmative statement that is false in a way that a reasonable patient would find important. Second, a material omission: leaving out a fact that a reasonable patient would need to interpret the advertisement correctly. Third, a false expectation: language, imagery or juxtaposition that leaves a reasonable patient with a mistaken impression about what the treatment can deliver, even if every individual statement is technically true.
IDFPR reads the "overall impression" prong seriously. A page that pairs a photograph of a slim, athletic patient with the text "our weight-management programme" implies an outcome even without saying anything false — and IDFPR has treated that construction as deceptive under the false-expectation prong. The safer construction is to keep imagery non-idealised, or to use the imagery only under a testimonial disclosure with a stated "results not typical" line.
Testimonials, before-and-after, and outcome claims
Testimonial and outcome-claim risk is the single highest-frequency source of Illinois disciplinary action against physicians on advertising grounds. Four rules apply to every testimonial an Illinois-licensed practice publishes.
- Identification. The testimonial must be identified as such — a review, a testimonial, a patient story — and not presented as an objective statement from an unrelated third party.
- Currency. Testimonials must be current. A testimonial about a service the practice no longer offers, a physician who has left, or a technique that has been superseded is misleading by omission.
- Consideration disclosure. If the testimonial-giver received anything of value in exchange for the testimonial — a discount, a gift, a service credit, a fee — that fact must be disclosed prominently on the same advertisement. This aligns Illinois practice with the federal FTC endorsement guides at 16 CFR Part 255.
- Typicality. If the outcome depicted is not what a typical patient would achieve, a clear "results not typical" line is required on the same page. IDFPR reads "clear" as the same font size, colour and proximity as the outcome claim it modifies.
Before-and-after imagery
Before-and-after imagery is testimonial content under Illinois review. Every set requires an on-image or immediately adjacent caption identifying the technique, the interval, the number of sessions, and — where relevant — the patient's age at the time of the "after" photograph. Retouching, filtering, lighting-standardisation and colour correction that alter the depicted outcome are treated as material misrepresentations. The audit trail — an unretouched original file, a date-stamped consent form, and a technique log — needs to be held for the six-year retention period used across the practice's HIPAA record set.
HIPAA overlay on testimonials
Any Illinois testimonial that identifies a patient — by name, photograph, condition or other identifier — is a use of PHI under the federal HIPAA Privacy Rule at 45 CFR 164.508. It requires prior written authorisation from the patient in the exact form the Privacy Rule specifies, and that authorisation must be revocable. State advertising rules do not relax federal HIPAA rules — everything is additive.
Credentials, specialties and titles
Illinois takes titling and credentialing claims seriously because they go directly to a reasonable patient's decision about who to see. The general standard is that any credential or specialty claim must be accurate, current, and referable to a recognised certifying body. Three specific tripwires recur.
- Board certification. The phrase "board-certified" is only safe when the certifying board is a member of the American Board of Medical Specialties (ABMS), the American Osteopathic Association Bureau of Osteopathic Specialists (AOA-BOS), or another body recognised by IDFPR. Certifications from private organisations that award them for a fee, without a defensible examination and training standard, cannot be shortened to "board-certified" — they must be identified by the full name of the certifying entity.
- Fellowship claims. "Fellowship-trained" implies a formal, accredited fellowship in the named specialty. A brief observership, a weekend course, or a non-accredited preceptorship does not qualify and cannot be advertised as a fellowship.
- "Specialist" and "specialising in". These phrases are permissible where the physician has substantial training and practice concentration in the area, but IDFPR has cautioned that they should not be used to imply a certification that does not exist. The safer construction is to describe the training and the practice concentration directly — "trained in reconstructive surgery, with 60% of the practice concentrated in that field" rather than "specialist in reconstructive surgery" alone.
Physician-supervised versus physician-performed
Illinois distinguishes between a service performed by a physician and a service performed by a non-physician under physician supervision. An ad that says "administered by our physicians" when the injection is in fact administered by a licensed practical nurse under supervision is deceptive under 225 ILCS 60/22(A)(3). The safer construction identifies the licensed provider category and the supervising physician by name.
Discounts, comparative claims and superlatives
Illinois permits discount and promotional pricing when the terms are clear and the offer is genuine. Four fail-modes recur in IDFPR proceedings on offer advertising.
- Phantom baseline. A "50% off" claim requires a genuine, prevailing reference price. Building a fictitious baseline solely to advertise a discount is deceptive under both 225 ILCS 60/22 and the state consumer-fraud statute.
- Expiration and eligibility. Every offer must state its expiration date and any material eligibility conditions on the same face as the offer.
- Bait-and-switch. Advertising a service at a price and then routinely upselling the patient to a more expensive alternative is prohibited unless the upsell is clinically indicated and separately consented.
- Inducement to unnecessary care. Offers that reward patients for undergoing services not medically indicated — free consultations tied to a purchase, discount codes for treatments the patient did not need — are treated as inducement under 225 ILCS 60/22 and can implicate the federal Anti-Kickback Statute for federally-reimbursed services.
Comparative claims
Comparative claims against another named practice or physician are risk-heavy in every US state and are especially exposed in Illinois. The safer pattern is to describe the practice's own capabilities and outcomes without reference to any named competitor. Categorical comparison to industry norms — for example, "our robotic-surgery volume is above the national average of X procedures per year, based on published federal data from [source and date]" — is defensible when the underlying data is public, verifiable, and cited.
Superlatives
Superlatives — "best", "top-rated", "leading", "premier" — are treated as suspect. Illinois inspectors read a superlative as an outcome claim that requires substantiation. The defensible construction cites a specific ranking source with the date and methodology on the same page, and links to the underlying methodology where the reader can inspect it. Superlatives without substantiation are the single most common IDFPR advertising finding on complaint-triggered inspection.
Digital advertising — SEO, ads, social, review platforms
Every rule above applies identically to digital surfaces. Four digital-specific patterns deserve separate calibration.
SEO and AI Overview content
Ranked or generative-AI-cited content that touches Illinois patients is subject to the same false-and-misleading standard as a print advert. Landing pages, condition explainers, and long-form guides need the same substantiation, currency, and typicality controls as paid media. AI Overview citations are particularly exposed because a fragment lifted out of context can become the ad in a search-result reading. Author every long-form healthcare page with a byline, a "medically reviewed by" line, a review date, and a link to sources — not because those signals ensure ranking, but because they preserve the substantiation trail an IDFPR reviewer will look for.
Paid search and paid social
Paid-search ad copy and paid-social creative are subject to two overlays in addition to Illinois: the ad platform's own healthcare policy (which varies by vertical and geography), and — for pixel-based tracking — the federal HIPAA rules on disclosure of PHI to third-party trackers. The Illinois-specific point is that the physician remains responsible for every claim in the ad copy, even when the ad platform inserts a dynamic-keyword-insertion phrase. Practices must build a review workflow that inspects every rendered ad, not just the templates.
Google Business Profile and directory listings
Directory content is advertising for Illinois purposes. Practice descriptions, service categories, opening hours, and photographs on Google Business Profile, health-directory profiles, insurance directories and physician-listing sites need the same currency and substantiation controls. A stale profile that lists a physician who has left, a service that is no longer offered, or an outdated credential is deceptive by omission under the false-expectation prong.
Review platforms and responses
The practice's own response to a patient review is advertising by the practice. Two failure modes recur. The first is confirming a patient's presence in a review response — that is a HIPAA disclosure regardless of what the reviewer said, and it exposes the practice to both federal HIPAA enforcement and Illinois deceptive-practice review. The second is publishing a rebuttal that names or characterises the specific care rendered — again a PHI disclosure. The safe response pattern is a de-identified, standard-form reply that thanks the reviewer, invites offline discussion, and does not confirm or deny the reviewer's status as a patient.
Enforcement patterns and disciplinary risk
Complaint-triggered inquiries
Most IDFPR advertising inquiries start with a complaint from a patient, a competitor, or a consumer group. The Board reviews the advertisement against the Act and the rules, and issues a request for response.
Cease-and-desist and consent orders
Common outcomes are cease-and-desist directives, consent orders requiring corrective advertising, mandatory attribution of prior misleading claims, and — where the conduct is serious or repeated — fines and licence suspensions.
Publication of discipline
IDFPR publishes discipline outcomes on its public licence-lookup portal. A finding of deceptive advertising is a permanent, searchable record against the physician's licence.
Consumer-fraud parallel actions
The Illinois Attorney General can bring a parallel action under 815 ILCS 505 with civil penalties, restitution, and injunctive relief separate from any IDFPR discipline.
Federal overlay — HIPAA, FTC, TCPA, ADA
Illinois advertising rules do not preempt or relax federal requirements. Every campaign that runs in Illinois must clear all of them.
- HIPAA Privacy Rule (45 CFR 164). Any advertising that uses PHI requires prior written authorisation. Any third-party tracker on a page that combines an IP address with a condition URL is a disclosure of PHI under the 2022/2024 OCR bulletins.
- FTC Act Section 5. Deceptive or unfair advertising is a federal violation independent of Illinois rules. The FTC endorsement guides at 16 CFR 255 are the operative standard for testimonials nationwide.
- TCPA (47 USC 227). Marketing texts and pre-recorded calls to patients require prior express written consent. Statutory damages are USD 500 to USD 1,500 per unlawful message and can aggregate in class actions.
- ADA Title III. Practice websites are places of public accommodation under most federal appellate readings. WCAG 2.2 AA is the operative reference standard, and Illinois inspectors have increasingly cited accessibility failures alongside deceptive-practice complaints.
Illinois advertising rules — common questions
Does Illinois preapprove physician advertising?
No. IDFPR does not preapprove advertising. It enforces the Illinois Medical Practice Act and 68 Ill. Admin. Code 1285 after publication. Never claim your advertising is "board-approved" — the correct framing is "reviewed against Illinois advertising rules".
What counts as false or misleading advertising in Illinois?
Under 225 ILCS 60/22(A)(3), advertising is deceptive when it contains a material misrepresentation, omits a material fact, creates a false expectation of results, or fails to disclose that a testimonial-giver received consideration. IDFPR reads the standard broadly — an ad that is technically true but misleading in overall impression can still trigger discipline.
Are patient testimonials allowed in Illinois?
Yes, when they are truthful, current, and disclosed as testimonials. If the outcome is not typical, a "results not typical" line is required. Consideration must be disclosed. Testimonials that identify a patient require prior HIPAA authorisation.
Can we use "board-certified" in Illinois advertising?
Yes, when the certifying board is a member of the ABMS, the AOA-BOS, or another IDFPR-recognised body. Ambiguous or unrecognised certifications must be identified by the full name of the certifying entity.
What about "best" or "top-rated" claims?
Superlatives without substantiation are the single most common IDFPR advertising finding on complaint-triggered inspection. Cite a specific ranking source with the date and methodology on the same page.
Does Illinois require an office address on advertising?
IDFPR expects advertising to identify the licensee and the primary practice address. Group-practice advertising must not imply that a named physician is available at every listed location if that is not the case.
Is this guide legal advice?
No. This is marketing best practice reviewed for alignment with the Illinois Medical Practice Act and IDFPR rules. Consult a licensed healthcare-marketing attorney and IDFPR before publishing.
Scope an Illinois-safe advertising review
Book a 30-minute call with a member of the ICG Global Leadership Team, email the US practice lead, or WhatsApp us in your time zone. Retainers are custom-scoped per engagement — from USD ~$250/month equivalent (approx Rs 20,000).
Continue the state-board stack
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.